Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : JMED - Jones Pharma (specialty pharmaceutical mfr) -- Ignore unavailable to you. Want to Upgrade?

To: Michael Burry who wrote (201)	2/26/1999 7:29:00 AM
From: babette spatz	Respond to of 268

At least someone reads this thread. It is one thing to have the warm and fuzzies about the sales force, and the fact that Jmed's numbers are up on paper, BUT I am down 10 points in the span of a year on the stock!

To: Michael Burry who wrote (201)	2/26/1999 7:56:00 AM
From: babette spatz	Read Replies (1) \| Respond to of 268

Mr. Burry. I read the article you referred to, YOU WROTE IT!! VERY CUTE. Since you are a font of information, perhaps you are really Mr. Jones, When was the last acquisition? When is the next one ? Actions speak louder than words. (Maybe you heard this once before.) If Jmed has been sitting on "a kitty of over $10 million" AT WHAT INTEREST RATE? they sure have not been spending it on those afore mentioned acquisitions in the last year. I am only interested in the return to shareholders not dead money in the bank.